Company Overview and News

 
Macau casino shares down 40 per cent since June as trade war deters Chinese high rollers

1m scmp
China’s crackdown on corruption and investors’ fears over the impact of the trade war on the economy have sent the stock prices of Macau’s top six casinos tumbling an average of 40 per cent since June, bringing their valuations back down to reasonable levels.
SCHYF WYNMF 0200 0880 SJMHY MDEVF 1128 506186 GLXYENT 1928 MS SJMHF SCHYY WYNMY

2
Materials lift ASX from six-month lows

2h theage.com.au
Australian shares recorded their best session in more than a month on Tuesday, as the materials sector lifted the ASX from a six-month low.
NCMGF NCM RIO RIO MALRY MIN BCHEY BEPTF BPT RTPPF NCMGY RIO RTNTF MALRF MS

2
Materials lift ASX from six-month lows

2h watoday.com.au
Australian shares recorded their best session in more than a month on Tuesday, as the materials sector lifted the ASX from a six-month low.
NCMGF NCM RIO RIO MALRY MIN BCHEY BEPTF BPT RTPPF NCMGY RIO RTNTF MALRF MS

2
Materials lift ASX from six-month lows

2h smh.com.au
Australian shares recorded their best session in more than a month on Tuesday, as the materials sector lifted the ASX from a six-month low.
NCMGF NCM RIO RIO MALRY MIN BCHEY BEPTF BPT RTPPF NCMGY RIO RTNTF MALRF MS

 
New data shows Chinese economy is cooling

3h theage.com.au
China's factory-gate inflation has cooled for a third straight month in September amid ebbing domestic demand, pointing to more pressure on the world's second-biggest economy.
MS

 
New data shows Chinese economy is cooling

3h watoday.com.au
China's factory-gate inflation has cooled for a third straight month in September amid ebbing domestic demand, pointing to more pressure on the world's second-biggest economy.
MS

 
New data shows Chinese economy is cooling

3h smh.com.au
China's factory-gate inflation has cooled for a third straight month in September amid ebbing domestic demand, pointing to more pressure on the world's second-biggest economy.
MS

 
China's factory-gate inflation cools for third month, points to slackening demand

5h theedgemarkets
BEIJING (Oct 16): China’s factory-gate inflation cooled for a third straight month in September amid ebbing domestic demand, pointing to more pressure on the world’s second biggest economy as it remains locked in an intensifying trade war with the United States.
MS

1
Bring on the Pain: Strategists Say Go Defensive in Asean Stocks

5h theedgemarkets
(Oct 16): With a little less than a quarter left of a year that’s already witnessed a trade war between the world’s two largest economies, higher oil prices and a still ongoing emerging-markets rout, what’s an investor in Southeast Asia to do?
NMR DBSDY PSKXF D05 8604 N33 DBSDF NRSCF PHSXY PSE MS

 
China's factory-gate inflation cools for third month, points to slackening demand

5h malaymail
BEIJING, Oct 16 — China's factory-gate inflation cooled for a third straight month in September amid ebbing domestic demand, pointing to more pressure on the world's second biggest economy as it remains locked in an intensifying trade war with the United States.
MS

 
US retail sales increase modestly, consumer spending strong

8h malaymail
WASHINGTON, Oct 16 — US retail sales barely rose in September as a rebound in motor vehicle purchases was offset by the biggest drop in spending at restaurants and bars in nearly two years.
MS

 
Yeti IPO Is Back on the Table Two Years Later

8h investorplace
The Yeti IPO is back on the table two years after the company first proposed the idea of going public.
DTK MS

61
5 Bank Stocks to Buy for This Week’s Earnings Reports

8h investorplace
The specter of higher interest rates creates a sense of uncertainty throughout the economy. As borrowing costs rise, profit margins fall, and many ventures become unprofitable altogether. However, the economy’s pain tends to become a gain for bank stocks. Charging more in interest pads the margins for banks after existing in a low-rate environment for the last few years.
CMA COST MA AXP BAC V BK MS

61
7 Stocks That Should Rally With Fresh Blood

8h investorplace
Do you think General Electric (NYSE:GE) should have fired its CEO? GE’s board did, letting John Flannery go after just 16 months in the job. On Flannery’s watch, GE stock lost 52% of its value and was booted off the Dow Jones after more than 100 years on the index.
IBM GE F GEC UL AAL SHLD NWL KHC GNE MS GM DHR IVZ

 
Are U.S. Oil Exports Really Unstoppable?

10h oilprice
Irina is a writer for the U.S.-based Divergente LLC consulting firm with over a decade of experience writing on the oil and gas industry.
MS

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...